3,560 material Form 8-K filings that 2,489 companies we cover made with the SEC in October 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). 2,508 of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
On October 7, 2026, NextNRG completed its reincorporation from Delaware to Nevada under a plan approved by stockholders on December 29, 2025, and filed new Nevada charter documents and certificates of designation for its Series A, B and C convertible preferred stock. The company said the move did not change its business, management, assets, liabilities or net worth, and its common stock continues to trade on Nasdaq under NXXT. Shareholders should note that stockholder rights are now governed by Nevada law and the new Nevada bylaws.
Reincorporation effective October 7, 2026; each common share and preferred share converted one-for-one into the Nevada corporation's equivalent
Amended and Restated Voting Agreement dated October 7, 2026, effective September 30, 2026, terminates on the later of required approvals (other than the Split Authorization) or December 31, 2028
Series A preferred carries a $10.00 stated value and a 10% annual dividend paid in common stock; holders are capped at 9.99% beneficial ownership
American Resources Corporation received a Nasdaq letter granting an additional exception through November 16, 2026 to file its delinquent quarterly reports for the periods ended March 31 and June 30, 2026. The company says it is working to file both reports before the earlier October 15, 2026 deadline, and that the Nasdaq letter has no immediate effect on the listing or trading of its Class A common stock under the symbol AREC.
Nasdaq granted an exception through November 16, 2026 to file the March and June 2026 Forms 10-Q, after an earlier October 15, 2026 deadline for the March report.
The June Form 10-Q became delinquent, which led the company to submit an updated compliance plan requesting more time.
The company is working toward filing both reports before October 15, 2026, and says the stock continues to trade on The Nasdaq Capital Market as AREC.
Envoy Medical entered a Dismissal Agreement on October 6, 2026, resolving litigation in the Delaware Court of Chancery brought by Atlas Merchant Capital SPAC Fund I LP. Atlas had alleged it was not allowed to redeem its Class A Common Stock in the company's September 2023 business combination. Under the agreement, all Atlas claims will be dismissed with prejudice and neither the company nor any other defendant must make a payment to Atlas.
Agreement dated October 6, 2026, resolves Delaware Court of Chancery litigation with Atlas Merchant Capital SPAC Fund I LP
Atlas's claims will be dismissed with prejudice, with no further proceedings on the Litigation
No payment is required from Envoy Medical or any other defendant to Atlas under the agreement
Filing dated October 7, 2026, signed by CEO Brent Lucas
Nasdaq granted Onfolio an extension, set in an October 5, 2026 letter, to regain compliance with its $2.5 million minimum stockholders' equity requirement by November 23, 2026. The company also did not meet the alternative market value or net income standards, and the filing states there is no assurance it will regain or maintain compliance. If it does not, Nasdaq Staff will issue a written delisting notice that the company may appeal to a Nasdaq Hearings Panel.
Nasdaq notified the company on May 26, 2026 that it failed to meet the $2.5 million minimum stockholders' equity requirement under Listing Rule 5550(b)(1).
Nasdaq's letter dated October 5, 2026 extends the compliance deadline to November 23, 2026.
The company may be subject to delisting if it fails to evidence compliance when filing its periodic report for the year ending December 31, 2026.
The letter has no immediate effect on the listing or trading of the common stock on the Nasdaq Capital Market.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.